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1 Introduction
In studies involving cell cultures, animal models, and clinical 
trials, whey proteins have shown to have protective properties 
against a number of pathological conditions. Tests have been 
performed on cancer mammary cells (LAURSEN; BRIAND; 
LYEKESFELDT, 1990), human leukemia cells (ROY  et  al., 
2001), various types of cancer cells (HÄKANSON et al., 1995; 
SVENSSON  et  al., 2000). In addition, protective action in 
human prostate cells (KENT; HARPER; BOMSER, 2003), 
inhibitory action in mammary cells and in a rat mammary 
carcinoma model (BARUCHEL; VIAUX, 1996), inhibition of 
growth and metastasis of murine melanoma (BEZAULT et al., 
1994), inhibition of hepatocellular carcinoma caused by 
Hepatitis C Virus (HCV) (IKEDA et al., 1998), inhibition of 
tumors in animal model systems (BOUNOUS; KONGSHAVN; 
GOLD, 1988; McINTOSH et al., 1995; McINTOSH; LE LEU, 
2001; DIAS et al., 2006) have also been tested. Whey proteins 
have been used in treatments of metastatic mammal and 
liver carcinoma (KENNEDY  et  al., 1995), skin papiloma 
(GUSTAFSSON et al., 2004), and humans submitted to neck and 
head cancer surgery (CHMIEL, 1997) as well as on treatments 
for human glioblastoma transplanted to rats (FISCHER, 2004). 
Studies with HIV-positive adults and children have also 
been carried out with some success (BOUNOUS et al., 1993; 
MORENO et al., 2005). Whey proteins have been reported to 
lower blood cholesterol (JACOBUCCI et al., 2001) and protect 
gastric mucosa against ulcerogenic drugs (ROSANELI et al., 
2002; ROSANELI et al., 2004; MEZZAROBA et al., 2006). 
Various physiological properties of milk whey proteins have 
been detailed in review articles (SGARBIERI, 1999; SGARBIERI, 
Resumo
Amostras de proteínas de soro de leite bovino (S-1 a S-5) foram testadas, in  vivo e in  vitro, para algumas propriedades nutricionais e 
bioatividades. Para os testes in vivo foram usados ratos da linhagem Wistar alimentados por 21 dias com dieta AIN-93G modificada quanto 
ao teor de proteína (12 g proteínas.100 g–1 de dieta). Os parâmetros nutricionais medidos não diferiram entre as proteínas do soro de leite 
administradas através das dietas. O teor de glutationa nos eritrócitos foi mais elevado para o grupo alimentado com a amostra S-3. No 
grupo alimentado com S-3, a secreção de citocinas (IL-10 e TNF-α) por células humanas mononucleares da circulação periférica, cultivadas 
no meio RPMI-1640, foi mais elevada na ausência do antígeno BCG do que em sua presença. A secreção de IL-4 foi inibida em todos os 
tratamentos. O IC50, concentração de proteína de soro necessária para inibir 50% da proliferação de células de melanoma de camundongo 
foi 2,68 mg.mL–1 de meio de cultura para a amostra S-3 e 3,66 mg.mL–1 para a amostra S-2. Com base nesses resultados concluiu-se que a 
amostra S-3 (concentrado de proteína de soro enriquecida com TGF-β e lactoferrina) produziu melhores respostas nutricional e imunológica 
quando comparada aos demais produtos testados. 
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Whey protein samples (S-1 to S-5) were tested in vivo and in vitro for nutritional properties and selected bioactivities. Weanling male Wistar 
rats fed modified AIN-93G (12 g protein.100 g–1) diets for 21 days were used the in vivo studies. The nutritional parameters did not differ 
among the protein diets tested. Erythrocyte glutathione content was considered high and was higher for S-3, but liver glutathione was the 
same for all dietary groups. For S-3, cytokine secretion (IL-10 and TNF-α) by human peripheral blood mononuclear cells (in RPMI-1640 
medium) was higher in the absence of antigen than in the presence of BCG antigen. Interleukin-4 secretion was repressed in all treatments. 
The IC50, whey protein concentration required to inhibit 50% of the melanoma cell proliferation, was 2.68 mg.mL
–1 of culture medium for 
the S-3 sample and 3.66 mg.mL–1 for the S-2 sample. Based on these results, it was concluded that S-3 (whey protein concentrate enriched 
with TGF-β and lactoferrin) produced better nutritional and immunological responses than the other products tested.
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2.3 Amino acid determination
The amino acids in the acid hydrolysates (110 °C, 6N HCl, 
22 hours) were identified on a cation exchange chromatographic 
column (amino acid analyzer), and post-column quantification 
was performed by ninhydrin reaction (SPACKMAN; STEIN; 
MOORE,1958) using a standard amino acid mixture from 
Pierce (USA). 
2.4 Protein solubility
Protein solubility in water (pH  4.6) was determined 
according to the standard method described by Morr et al. (1985).
2.5 Biological assays
The experiments on rats were performed at the Biological 
Test Laboratory, Department of Food and Nutrition (DEPAN), 
School of Food Engineering (UNICAMP), Campinas-SP 
and were approved by the Ethics Committee for Animal 
Experimentation/Unicamp through protocol number 1065-1.
Forty Specific Pathogen Free (SPF) weanling (21 days) male 
Wistar rats were used in the biological assays. The rats were 
provided by the Center for Multidisciplinary Investigations in 
Biology (CEMIB) of the University of Campinas (UNICAMP). 
At the beginning of the experiment, the average body weight of 
the rats was 57.9 ± 7.3 g. The diets were based on the AIN-93 
(REEVES; NIELSEN; FAHEY, 1993) standard diet for laboratory 
rodents (American Institute of Nutrition), in which 12% of 
whey protein product was substituted for the recommended 
17% casein. The 5% difference in protein concentration 
was compensated by adding an extra 5% carbohydrate. The 
animals received water and diet ad libitum throughout the 
experiment. The environmental conditions of the laboratory 
were maintained under controlled temperature at 22 ± 2 °C and 
alternate 12 hours periods of light and darkness.
The experimental protocol for the rat assay is shown in 
Figure 1. Weight gain, blood glutathione, and liver glutathione 
were measured after 7 and 21 days of diet administration.
2.6 Glutathione determination
Blood erythrocyte and liver glutathione (GSH) levels were 
determined using the glutathione reductase method described 
by Griffth (1980).
2.7 Cultivation of murine melanoma cells 
B16F10 murine melanoma cells were provided by the 
Ludwig Institute, Lausanne, Switzerland. The cells were grown 
in 75 cm3 flasks in RPMI-1640 medium (GIBCO) supplemented 
with 10% inactive fetal bovine serum (CULTILAB), 2 mM of 
L-glutamine (SIGMA CHEMICAL COMPANY), 1 mM sodium 
pyruvate, and the antibiotics streptomycin 0.1 mg.mL–1 and 
ampicilin 0.1 mg.mL–1 (FONTOURA WYETH AS). Prior to 
adherence, the cells were cultivated to maintain and multiply 
the strain to be frozen in the medium (RPMI-1640) with 10% 
dimethylsulfoxide (DMSO, SIGMA CHEMICAL COMPANY) 
and then stored in liquid nitrogen (GERAN, 1972).
2004; MARSHALL, 2004). These properties can be summarized 
as follows: antitumoral action through GSH (glutathione) 
and lymphocytes stimulation and immunoglobulin synthesis, 
and production and propagation of antioxygen free-radicals 
(ROS); protection of DNA through neutralization of toxic 
and procarcinogenic substances, stabilization of DNA 
through methylation of specific DNA sites, protection of 
the gastrointestinal mucosa by stimulation of prostaglandin 
synthesis (PGE2, PGI2); stimulation and formation of mucus, 
and inhibition of gastrin, antiviral, and antibacterial activities.
The objective of the present research was to compare the 
properties of five different Whey Protein Concentrates (WPC) 
or isolates (WPI) with respect to their capacity to promote 
body growth and stimulate glutathione (GSH) synthesis by 
hepatocytes and erythrocytes (in rats). In addition, this study 
also aimed to stimulate (in vitro) the secretion of cytokines by 
healthy Human Peripheral Blood Mononuclear Cells (HPBMC), 
in the absence or presence of the antigen from Bacillus Calmette-
Guérin (BCG) vaccine, and inhibit the proliferation of murine 
melanoma cells.
The ultimate aim of this work was to select one of the 
products to be used as a food supplement to possibly ameliorate 
infection and/or inflammation in conditions such as mucositis 
(in chemotherapy), pediatric cystic fibrosis, and adult Chron’s 
disease.
2 Materials and methods
2.1 Whey protein products
The whey protein products investigated in this study were 
denominated S-1 to S-5 samples. S-1, S-2 and, S-3, kindly 
provided by Hilmar Ingredients, a division of Hilmar Cheese 
Company, California, USA. S-1 (HilmarTM 8000) is a whey 
protein concentrate (WPC); S-2 (HilmarTM 8350) a whey protein 
hydrolysate (WPH); and S-3, a Hilmar experimental product, 
which is a WPC enriched with TGF-β, a cell transforming 
factor, and lactoferrin; S-4 (AlacemTM), a WPC purchased from 
New Zealand Milk Products (NZMP-São Paulo, BR) and S-5, 
an experimental product (WPI) produced in Rennes, France.
The starting material for all Hilmar products was cheese 
whey submitted to microfiltration, ultrafiltration, diafiltration, 
and dehydration by spray-drying. The S-2 (WPH) sample was 
obtained by enzymatic hydrolysis of the commercial WPC, the 
hydrolysate was then concentrated and dehydrated by spray-
drying.
S-5, a Whey Protein Isolate (WPI) was obtained after 
microfiltration to separate casein micelles, following by 
ultrafiltration, diafiltration, and lyophilization.
2.2 Basic chemical analysis
Dry extract, ash, protein, and moisture contents were 
determined according to the procedures described in the AOAC 
(ASSOCIATION…,1990); total lipids, by the method of Bligh 
and Dyer (1959), and lactose according to the method described 
by Acton (1977).
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2.9 Cytokine modulation evaluation
Cytokine secretion and modulation (GAINES; ANDERSON; 
BIBERFED, 1996) in Human Peripheral Blood Mononuclear 
Cells (HPBMC) were analyzed using cultivated (2 × 106 cells.
mL–1) in round-bottomed, 96-wells tissue culture plates in 
the presence or absence of the BCG antigen (BCG Moreau, 
FIOCRUZ, Rio de Janeiro, Brazil; Bacillus Calmette – Guérin 
vaccine, 5  ×  105  UFC.mL–1, Butantan Institute, SP, Brazil). 
RPMI – 1640 basic culture medium (Sigma, Saint Louis, Mo, 
USA) was used. 
The protein concentration used throughout the assays was 
200 µg.mL–1 of culture medium. Eight independent assays were 
performed for the cytokines (IL-4, IL-10, TNF-α).
The RPMI-1640 medium was supplemented with 10% 
human serum AB-HNS (SIGMA, USA), 1% glutamine, and 0.1% 
gentamicin (SIGMA, USA). Plates containing suspended cells 
were incubated at 37 °C, 5% CO2, and 95% air in a humidified 
atmosphere chamber. After 48 hours of incubation, supernatants 
were collected and stored at –80  °C until assays for cytokine 
concentration were carried out. Peripheral blood mononuclear 
cells were collected from eight healthy individuals, and 
independent assays were performed for the cytokines (IL-4, IL-
10, TNF-α). TNF-α (tumor necrosis factor alpha), interleukin-4 
(IL-4), and interleukin-10 (IL-10) were determined in the 
supernatant cultures (duplicate reading) on a two-MAb sandwich 
ELISA (DUO SET®, R&D SYSTEMS, MINEAPOLIS, MN, USA) 
in flat-bottomed MultiSorp ELISA plates (NUNC, DENMARK), 
according to the manufacturers’ protocols. Recombinant 
cytokines were used for the standard curves.
2.10 Statistical analysis
Differences in weight gain, blood glutathione, and liver 
glutathione were tested for statistical significance by using Basic 
Statistics and Tables software to perform a variance analysis 
and identify differences between the means in accordance with 
the Duncan or the Tukey tests at p  <  0.05 (GOMES, 1982). 
The statistical analysis for cytokines was performed utilizing 
SPSS software. Descriptive data were expressed as medians of 
minimum and maximum values found. The differences between 
the groups were analyzed using the Wilcoxon test (p < 0.05). 
3 Results
3.1 Samples composition and characterization
Table 1 shows the basic chemical composition of the various 
whey protein samples studied. The protein content ranged from 
76% (S-1) to 92.6% (S-5). Moisture content varied from 3.4% 
(S-5) to 6.7% (S-3); ash from 1.3% (S-4) to 5.6% (S-2); fat from 
1.0% (S-5) to 11% (S-3); and lactose from 0.9% (S-5) to 8.5% 
(S-3).
Table 2 shows the amino acid profiles of all five whey protein 
samples. The profiles are typical of the amino acid composition 
of whey proteins: high in leucine, lysine, sulfur-containing 
amino acids, tryptophan and threonine, and glutamic and 
aspartic acids.
 Suspensions of B16F10 adherent cells were obtained 
by treating the cultures with 0.2% trypsin (VINDELOV; 
CHRISTENSEN; NISSEN, 1983) for 5  minutes and then 
deactivating them in 10% fetal bovine serum. The non-
adherent cells were centrifuged twice and then ressuspended 
in the supplemented RPMI-1640 medium. A Malassez camara 
was used to count cells. Cell concentration was adjusted to 
5 × 105 cells.mL–1 for the RPMI-1640 medium supplemented 
with 10% fetal bovine serum and 7 g of Polimixin-B (SIGMA 
CHEMICAL COMPANY, ST LOUIS MO-USA). Cell viability 
was determined through an exclusion test and measurement of 
cellular permeability using the reagent Trypan Blue. Only non-
viable cells are permeable to the reagent and are stained. Viable 
cells are given by the difference between total and stained cells. 
Over 95% of the cells were viable.
2.8 Cytotoxicity assay – MTT
The viability of tumoral cell strain after 24  hours of 
treatment with whey protein, concentrations ranging from 
0.1 to 10.0 mg.mL–1, was determined using MTT colorimetric 
assays (3-(4,5-dimethylthiazol-2-y1)2,5-diphenyl tetrazolium 
bromide), as described by Mosmann (1983). This method is 
based on the reduction of the MTT to formazan by living cells. 
The non-viable cells were identified using tumor cell suspensions 
incubated in 96-well plates under sterile conditions. Aliquots 
of 10 µL of MTT (5 mg.mL–1) were added to the suspensions, 
which were incubated for 3 hours at 37 °C in an oven containing 
5% of CO2. Next, the culture medium was removed and 
100 µL of DMSO were added to dissolve the formazan crystal, 
which remained as a blue precipitate. Absorbances were read 
using ELISA plate at a wave length of 540  nm (TITERTEK 
MULTISKAN).
Figure 1. General protocol for the rat assay. Letter G followed by roman 
numbers (I to V) identify the experimental groups, and the letter S 
followed by arabic numbers (1 to 5) identify the experimental samples. 
S-1: commercial WPC; S-2: commercial WPH; S-3: experimental WPC 
(TGF-β and LF enriched); S-4: commercial WPI; and S-5: experimental 
WPI. G-I to G-V, rat experimental groups.
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Protein solubility (water at pH 4.6) was close to 100% for 
S-4 and S-5 and around 90% for samples 1, 2, and 3. 
3.2 Biological assay
According to the general protocol, after 7 days, there were 
no statistical differences in the weight gain among the five 
groups of rats (GI to GV) fed commercial ration (Figure 1), 
and the average was 37.1 ± 4.6 g. The growth rate of the rats on 
experimental diets for 21 days is shown in Figure 2. Once again, 
there were no differences in the rates of growth among the five 
groups; all groups presented continuous growth curves. Average 
dietary consumption and average weight gain during 21 days of 
experiment were 343.8 ± 10.0 g and 107.5 ± 3.2 g, respectively. 
Total glutathione (GSH) concentrations in the blood 
erythrocytes and liver tissues were determined after 7 and 21 
days on special whey protein diets. Figure 3 presents the results 
for blood erythrocytes (mmol.L–1). Comparing the results of 
the erythrocyte glutathione content obtained for all five dietary 
Table 2. Complete amino acid profiles of five whey protein products.
Amino acid
(% of total AA)
Samples
S-1 S-2 S-3 S-4 S-5
Essential
Histidine 1.6  1.5 1.9 2.0 1.7
Isoleucine 6.1 6.0 5.8 5.0 6.0
Leucine 10.3 10.2 10.3 12.8 12.4
Lysine 10.1 10.8 8.6 10.2 10.4
Methionine 2.1 2.0 3.1 2.4 3.0
Cystine/CySH 2.8 1.7 2.3 2.5 2.9
Phenylalanine 3.0 3.1 3.5 3.4 4.1
Tyrosine 3.2 2.7 3.2 3.3 3.9
Tryptophan 1.7 1.3 ND 2.0 2.5
Valine 5.7 5.6 5.3 4.8 5.8
Threonine 6.5 7.4 6.3 4.7 5.3
Non-essential
Alanine  4.9 5.3 5.0 5.3 4.8
Arginine 2.4 2.7 3.3 2.4 2.9
Aspartic acid 10.4 11.0 10.9 11.5 11.5
Glutamic acid 16.9 15.7 16.9 17.6 18.1
Glycine 1.7 1.9 2.1 1.6 2.0
Proline 5.7 5.9 5.9 4.1 5.0
Serine 5.0 5.2 5.5 3.8 4.8
S-1: commercial WPC; S-2: commercial WPH; S-3: experimental WPC (TGF-β and LF 
enriched); S-4: commercial WPI; S-5: experimental WPI. ND, not determined. Results 
are average values of duplicate analysis for each sample.
Figure 2. Growth rate of 5 groups of Wistar rats treated with different 
whey protein samples: S-1: commercial WPC; S-2: commercial WPH; 
S-3: experimental WPC (TGF-β and LF enriched); S-4: commercial 
WPI; and S-5: experimental WPI.
Table 3. Percentage of cytotoxicity (cell death)* of B16F10 murine 
melanoma cells caused by the whey protein products tested. 
Samples
(S)




















*Average in duplicate. Sample 1 was not submitted to this test; S-2: commercial 
WPH; S-3: experimental WPC (TGF-β and LF enriched); S-4: commercial WPI; S-5: 
experimental WPI.
treatments at day 7 (gray columns), samples S-1, S-3, and S-4 
were higher (p < 0.05) than samples S-2 and S-5. However, at 
day 21, only the group of animals treated with sample S-5 was 
lower than the others (p < 0.05). On the other hand, comparing 
the results for the individual dietary groups at day 7 and day 21, 
the samples S-2, S-3, and S-5 were statistically higher at day 21, 
while the samples S-1 and S-4 were not different at days 7 and 
21 (p > 0.05) 
As for liver GSH (Figure 4), no differences were found at day 
7 or 21 comparing all five treatments. However, comparing each 
treatment separately, the glutathione concentration of S-1, S-2, 
and S-3 treatments was lower at day 7 than at day 21(p < 0.05).
3.3 Cytotoxicity on B16F10 murine melanoma cells
Table 3 shows the percentage of B16F10 murine melanoma 
cell death for the whey protein samples (S-2 to S-5) evaluated 
in vitro using two different concentrations (2.5 and 5 mg.mL–1 of 
culture medium). The cytotoxicity found on melanoma B16F10 
cells was the highest (70%) in the S-2 medium at 5 mg.mL–1, 
followed by S-3 and S-4 with 48 and 42% toxicity, respectively. The 
IC50 (protein concentration to inhibit 50% of cells replication) was 
obtained from in vitro testing of S-2 and S-3 samples on B16F10 




S-1 S-2 S-3 S-4 S-5
Protein (wet basis) 76.0 73.8 70.6 89.3 92.6
Moisture 6.2 5.1 6.7 5.6 3.4
Ash 3.6 5.6 2.8 1.3 2.1
Fat 6.7 6.8 11.0 1.8 1.0
Lactose 5.7 5.5 8.5 2.0 0.9
Protein (dry basis) 81.0 77.8 75.7 94.6 95.8
S-1: commercial WPC; S-2: commercial WPH; S-3: experimental WPC (TGF-β and LF 
enriched); S-4: commercial WPI; S-5: experimental WPI.
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protein products was studied in culture medium with or without 
the presence of an antigen (BCG) and with 200  µg.mL–1 or 
without the presence of whey proteins (controls). The cytokines 
studied were interleukin-10 (IL-10), the tumor necrosis factor 
alpha (TNF-α), and interleukin-4 (IL-4). 
Table 4 shows the effect of the whey protein samples on 
cytokine secretion by HPBMC in the absence of BCG. 
With respect to IL-10 secretion, a comparison between 
the stimulatory capacity of control and culture medium the 
capacity of the culture medium containing whey protein 
samples (200 µg.mL–1) indicates that samples 1, 2, and 3 were 
significantly higher compared to S-4 and S-5, and that sample 
3 had the highest activity. With regard to TNF-α, only S-3 and 
S-1 significantly differed from the control. None of the whey 
proteins differed from the control medium with respect to the 
secretion of interleukin-4 (IL-4) in the absence of BCG.
In the presence of BCG, all whey protein samples stimulated 
the secretion of IL-10 (Table 5) compared to the control medium 
containing only BCG. However, BCG repressed the stimulation 
of TNF-α and IL-4 in all samples studied.
4 Discussion
The gross chemical composition of the whey protein 
products studied varied depending on the methods of 
preparation and the classification as WPC (Whey Protein 
Concentrate) or WPI (Whey Protein Isolate). The principal 
variation observed was in protein content (dry basis), which 
ranged from 76-81% for samples S-1, S-2, and S-3 but was 
approximately 95% for S-4 and S-5.
The lower solubility of sample S-2 was not expected since 
a protein hydrolysate the solubility should be higher than for 
the non-hydrolyzed WPC. This may be attributable to Maillard 
type reactions or some other type of molecular interaction 
during hydrolysis and/or drying since the color of this sample 
was darker than that of the others (SGARBIERI; FARFAN; 
TANAKA, 1973).
The amino acid composition of the whey proteins analyzed 
was similar and characteristic of such products.
The total growth and the growth rate curves produced by 
the whey protein samples investigated were also similar.
Tissue glutathione content was measured in the blood 
(erythrocytes) and in liver after 7 and 21 days of protein dietary 
treatment and showed some significant variations (p < 0.05) 
between these two periods of treatments.
Figure 3 shows the effect of the various protein diets on total 
glutathione concentration in the rat erythrocytes. After 7 days 
of feeding, higher GSH levels were found for S-1, S-3, and S-4 
protein diets (p < 0.05) than those of S-2 and S-5. However, 
no difference was observed among the first three samples or 
between the last two. 
There is no apparent reason why S-5 should have shown 
a lower erythrocyte GSH after 7 days of feeding. It has been 
repeatedly suggested (BOUNOUS; KONGSHAVN; GOLD, 
1988; BOUNOUS; GOLD, 1991) that the extent of tissue 
melanoma cells. The IC50 for S-2 was 3.66 mg.mL
–1, and that for 
S-3 was 2.68 mg.mL–1. With regard to IC50 and B16F10, melanoma 
tumor cells, product 3 showed higher bioactivity at lower protein 
concentration (2.5 mg.mL–1 of culture medium). The quadratic 
equations below allowed the calculation of the IC50 (mg.mL
–1) for 
samples S-2 (Equation 1) and S-3 (Equation 2). 
y = 3.1726x2 + 1.1013x + 3.5006 (R2 = 0.9947) (1)
y = 7.929x2 – 4.3915x + 4.8594 (R2 = 0.9787) (2)
In Equations 1 and 2, y stands for 50% inhibition of cell 
replication (IC50),  ×  for protein concentration in the culture 
medium (mg.mL–1), and R2 for the coefficient of determination.
3.4 Cytokine secretion by human peripheral mononuclear 
cells (HPBMC)
The modulation of cytokine secretion in Human Peripheral 
Blood Mononuclear Cells (HPBMC) by the various bovine whey 
Figure 3. Erythrocytes glutathione concentration (mmol.L–1) of blood 
after 7 and 21 days on the special protein diets. Lowercase letters (a, 
b) compare all dietary treatments at 7d or 21d. Capital letters (A, B) 
compare each dietary treatment at 7d with 21 days of feeding the diets. 
S-1, commercial WPC; S-2, commercial WPH; S-3, experimental WPC 
(TGF-β and LF enriched); S-4, commercial WPI; and S-5, experimental 
WPI. G-I to G-V, rat experimental groups.
Figure 4. Effect of feeding different whey protein diets for 7d and 
21d on rat liver glutathione (GSH). Lowercase letters (a) compare all 
dietary treatments at 7 or 21d. Capital letters (A, B) compare each 
dietary treatment at 7d with 21d of feeding the diets. S-1: commercial 
WPC; S-2: commercial WPH; S-3: experimental WPC (TGF-β and LF 
enriched); S-4: commercial WPI; and S-5: experimental WPI. G-I to 
G-V, rat experimental groups.
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an injection of 106 Sheep Red Blood Cells (SRBC) 7 days prior 
to sacrifice, procedure not done in the present experiment. 
Furthermore, a different analytical method using a colorimetric 
assay to determine GSH (SAVILLE, 1958) was used in previous 
studies, in which the maximum liver GSH concentration was 
detected at approximately 5 to 7 days post-immunization. 
A strong correlation has been demonstrated between GSH 
concentration in the liver and increased immunoglobulin in 
the mice spleen (BOUNOUS; KONGSHAVN; GOLD, 1988; 
DIAS et al., 2006).
In the present study, there was no immunization prior to 
GSH determination at either 7 or 21 days of protein diet feeding. 
No statistical difference was found in the rat liver for all five 
protein dietary groups at both 7 and 21 days of feeding. However, 
increased GSH contents were detected at day 21 for the rat 
groups fed the protein samples S-1, S-2, and S-3 (p < 0.05), which 
differed from the groups that received S-4 and S-5 samples and 
showed identical liver GSH concentration after 7 and 21 days.
Comparing the results of previous published studies 
(BOUNOUS; KONGSHAVN; GOLD,1988; DIAS et al., 2006) 
with the data presented in this paper, we were tempted to 
suggest that immunization speeds up GSH synthesis in the 
stimulation of GSH synthesis, on feeding rodents with whey 
proteins, depends on the concentration of total S-amino acids 
in the protein samples, mainly cystine/cysteine. 
Our data (Table  2) shows the lowest concentration of 
S-amino acids in S-2 sample, which seems to justify the lower 
GSH content in the group of rats that received this product. 
In contrast, no apparent reason explains why S-5 with higher 
S-amino acids content showed lower erythrocyte GSH at day 7. 
This result seems to contradict the hypothesis that tissue GSH 
concentration depends only on S-amino acids in whey proteins. 
The data presented suggest that other factors are also 
capable of influencing GSH concentration in the erythrocytes. 
Factors such as production technology and post-production 
handling of samples may be of importance influencing not only 
composition but also amino acid bioavailability.
Higher liver GSH (µmoles.g–1 fresh tissue) for whey 
proteins than for other dietary proteins have been reported in 
previous studies (PACHECO; SGARBIERI, 2005; DIAS et al, 
2006), including one study concerning a pilot WPC produced 
experimentally in Tecnolat, ITAL (ZINSLY  et  al., 2001). In 
these experiments, the rats and/or mice were stimulated with 



























































1Medium RPMI-1640: Culture medium at concentration of 5 × 105 CFU/monocytes. S-1: commercial WPC; S-2: commercial WPH; S-3: experimental WPC (TGF-β and LF enriched); 
S-4: commercial WPI; S-5: experimental WPI. NS, not significant. Data expressed as median of (minimum and maximum) values.
Table 5. Effect of the five whey protein products on cytokine secretion in supernatant culture of human peripheral blood mononuclear cells 



























































1BCG: Bacillus Calmette-Guérin (Instituto Butantan, São Paulo, SP). S-1: commercial WPC; S-2: commercial WPH; S-3: experimental WPC (TGF-β and LF enriched); S-4: commercial 
WPI; S-5: experimental WPI. Data expressed as median of (minimum and maximum) values. NS, not significant.
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(GRIFFTH, 1980; BOUNOUS; GOLD, 1991; BARUCHEL; 
VIAUX, 1996; SGARBIERI, 2004; MARSHALL, 2004).
In addition to its antioxidant action, GSH is also involved 
in many biological processes (SGARBIERI, 2004; MARSHALL, 
2004), promotes cytotoxic activity, and plays an important 
role in the proliferation of T-cells and synthesis of IL-8 
(TREITINGER  et  al., 2004). Antioxidants and glutathione 
precursors have been shown to down regulate pro-inflammatory 
cytokine production (HADDAD et al., 2001).
Cytokines can have either beneficial or detrimental effects, 
depending on the metabolic context considered and the 
amounts produced. Although cytokines are essentially beneficial 
in cases of infections, they may be detrimental in cancer, chronic 
inflammatory diseases, or in individuals infected with HIV 
(CROSS; GILL, 1999).
Type  1 T-helper (Th1) cells produce interferon-gamma 
(IFN-γ), IL-2 and TNF-α, whereas type 2 (Th2) cells produce IL-
4, IL-6, and IL-10. The Th1 cytokines (IFN-γ and IL-2) increase 
cellular immunity, whereas the Th2 cytokines (IL-4, IL-5, IL-6 
and IL-10) increase humoral immunity (ABBAS; LICHTMAN; 
PILLAI, 2008).
The balance of the two types of cytokine populations is 
important for the maintenance of immune homeostasis in the 
host. Once the balance is lost, various immunological diseases 
such as allergies and infections may occur (GRIMBLE, 1998; 
MATSUZAKI; CHIN, 2000).
According to various authors (GRIMBLE, 2001; 
GRIMBLE et al., 2002; MATSUZAKI; CHIN, 2000), there is an 
inverse relationship between inflammation and T-cell function. 
Inflammation initiates with the secretion of pro-inflammatory 
cytokines IL-1, IL-6, and TNF-α, which induce the production 
of oxidants (free-radicals) causing pathogen death, damage to 
tissues, and release of nutrients (glucose, glutamine, S-amino 
acids), which serve to nourish the immune cells (T and B) and 
as substrates for the synthesis of GSH.
In a controlled situation, expression of IL-10 by Th2 
cells should act in a feedback inhibition, which also involves 
production of IL-1 receptor antagonist (IL-1 ra) resulting 
in the down regulation of nuclear factor-kapa B (NF-kB) 
by enhancement of antioxidant defenses. In these anti-
inflammatory and antioxidant processes, both IL-10 and GSH 
play an important role. 
Failure to terminate the inflammatory response, once its 
primary purpose of defeating pathogens has been achieved, may 
result in immune suppression and hyper inflammation, oxidant 
damage (insufficient antioxidant supply), and excessive loss of 
body tissue components.
Nutritional support in the form of proteins, individual 
amino acids and antioxidants, can increase the availability 
of substrates for synthesizing peptides and proteins for 
regulating inflammatory processes (MATSUZAKI; CHIN, 2000; 
GRIMBLE et al., 2002).
According to our test results for: a)  gross chemical 
composition and amino acid profiles of the concentrates and 
isolates tested; b) stimulation of GSH synthesis; c) cytotoxicity 
rat liver making it to peak at around 7 days after the antigen 
challenge. On the other hand, in the absence of immunization, 
the liver GSH peak seems to occur at a later period of feeding 
the protein diet.
The highest level of toxicity (70%) for murine melanoma 
cells was produced by the medium containing S-2, followed by 
that containing S-3 (48%), both under product concentration of 
5 mg.mL–1 of culture medium. At the the lowest concentration 
(2.5  mg.mL–1) of medium, S-3 sample presented the highest 
cytotoxicity (42.3%). In terms of IC50, S-3 sample exhibited 
higher activity, 2.68 against 3.66 mg.mL–1 for S-2.
Assays for IL-10 and TNF-α in the absence of antigen (BCG) 
in the culture medium showed S-1 and S-3 to be distinctly 
higher for stimulating the secretion of these cytokines, especially 
considering that the degree of stimulation of S-4 and S-5 samples 
was zero. None of the whey protein samples tested under the 
assay conditions stimulated the IL-4.
In the presence of BCG antigen none of the five whey 
protein preparations stimulated the secretion of either TNF-α or 
IL-4. In contrast, all five preparations stimulated the secretion of 
IL-10 (p < 0.05), and S-1 and S-2 were the most effective. BCG 
antigen was chosen because it has been used as a vaccine against 
peripheral blood mononucleosis, and previous results have 
shown that it is an effective stimulator of cytokine production 
in Human Peripheral Blood Mononuclear Cells (HPBMC) 
cultures.
In the case of samples S-1 and S-3, the high erythrocytes 
concentrations of GSH after 7 days of feeding were associated 
with high rates of secretion of IL-10 and TNF-α.
The precise significance of these observations is difficult 
to explain due to the fact that GSH concentrations were 
determined in rat assays, whereas the IL-10 and TNF- α  levels 
were determined in culture supernatants in Human Peripheral 
Blood Mononuclear Cell (HPBMC). Nevertheless, it appears to 
be significant that IL-10 (a regulatory interleukin), TNF- α (a 
multifunctional immune modulator), and GSH were stimulated 
both in vitro and in vivo in the absence of the antigen. 
Cross and Gill (1999) have shown that, in  vitro, whey 
proteins suppresses T and B lymphocytes proliferative responses 
to mitogens and the cytokine (IFN-γ and IL-4) secretion. 
Furthermore, in mice, whey protein have been shown to enhance 
splenic immune response to sheep red blood cells (BOUNOUS; 
KONGSHAVN; GOLD,1988; BOUNOUS; BATIST; GOLD, 
1989; BOUNOUS; GOLD, 1991).
In HIV-infected children, increased GSH has been found 
following whey protein supplementation (BARUCHEL, 
1998; MORENO et al., 2005). It has also been demonstrated 
(CAYOTA  et  al., 1996), in  vitro, that the ability of HIV-
infected individuals to proliferate TCD4 is correlated with GSH 
restoration.
The immune modulation mechanisms of whey proteins 
seem to be related to their amino acid profiles since such proteins 
contain large amounts of cysteine, glutamate, and glutamyl-
cysteinyl peptides, all of which contribute to GSH synthesis 
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PMid:15026350. http://dx.doi.org/10.1158/0008-5472.CAN-03-
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of the products on B16F10 murine melanoma cells; and 
d) cytokines (IL-4, IL-10 and TNF-α) secretion by HPBMC; it 
is clear that S-1 and S-3 were the most bioactive materials. S-3 
sample was the strongest secretor of TNF-α and IL-10, while the 
five samples were similar with respect to all other characteristics. 
S-3 sample is a WPC enriched approximately ten-fold in 
TGF-β and lactoferrin. The TGF-β, a dimmer molecule with 
112 amino acids residues and molecular mass of approximately 
25 kD, inhibits the proliferation of a variety of normal epithelial 
cell types and hematopoietic stem cells, and therefore it is useful 
in preventing epithelial cell damage during chemotherapy 
(IWATA et al.; 1999; SONIS et al.; 1994).
Recent investigations revealed (BECKER; FANTINI; 
NEURATH, 2006) implications of TGF-β in the suppression 
of T-cells mediated autoimmune inflammation, anti-tumor 
immunity, and in modification of Th cells (Th1 and Th2) into T 
regulatory cells (Threg), which seem to be important in the down 
regulation of inflammatory processes.
The epithelial anti-proliferation and anti-inflammatory 
effects on T-cells of TGF-β, in combination with the 
immunomodulatory, antioxidant, and antibacterial and antiviral 
properties of lactoferrin, reinforced our hypothesis that the 
product represented by S-3 should be particularly helpful as 
a food supplement in combating infectious and inflammatory 
processes associated with pathological conditions such as 
mucositis, a side effect of chemotherapy, cystic fibrosis, and 
Chron’s disease.
5 Conclusion
In the present research, S-3 (a WPC enriched with TGF-β 
and lactoferrin) was associated to high in  vitro IC50 against 
melanoma cells, and to a strong stimulation of TNF-α and 
interleukin-10 secretion by human peripheral mononuclear cells 
in the absence of stimulating antigen. Among the whey protein 
samples assayed, S-3 was therefore considered potentially 
adequate to be used as a dietary supplement for attenuating 
primary infectious and inflammatory processes associated with 
different pathologies.
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